ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Polymer Platinate Begins Testing In Phase I Trial.

September 29, 2000

Nurse Participation In International Congress Increases

September 19, 1986

June Panel Meeting Dropped

June 3, 1977

NIH Tells Grant Applicants One Resubmission Is Enough.

October 24, 2008

In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director

July 29, 1988

“Leadership Vacuum: At NCI Allows NIH To Look At Reorganization, Varmus Says

November 4, 1994